Literature DB >> 3963013

Pharmacokinetics of flurbiprofen.

D G Kaiser, C D Brooks, P L Lomen.   

Abstract

Both radiolabeled and nonlabeled drug have been used to study the pharmacokinetics of flurbiprofen (Ansaid, Upjohn). Drug absorption is rapid, drug disappearance half-life is independent of oral dose, and the area under the plasma drug concentration versus time curve increases with increasing oral dose. Elimination of intact drug from the peripheral circulation is biphasic and rapid. Following a single oral dose of 100 mg of flurbiprofen, drug bioavailability is equivalent using regimens of four 25-mg tablets, two 50-mg tablets, or one 100-mg tablet once daily. Long-term administration of flurbiprofen appears neither to inhibit nor induce the drug's metabolism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3963013     DOI: 10.1016/0002-9343(86)90104-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

Review 1.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

2.  Plasma and cerebrospinal fluid pharmacokinetics of flurbiprofen in children.

Authors:  Elina Kumpulainen; Pyry Välitalo; Merja Kokki; Marko Lehtonen; Andrew Hooker; Veli-Pekka Ranta; Hannu Kokki
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of flurbiprofen and its enantiomers.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

Review 4.  Single dose oral flurbiprofen for acute postoperative pain in adults.

Authors:  Asquad Sultan; Henry J McQuay; R Andrew Moore; Sheena Derry
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

5.  Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue.

Authors:  Stefan Saretz; Gabriele Basset; Liridona Useini; Markus Laube; Jens Pietzsch; Dijana Drača; Danijela Maksimović-Ivanić; Johannes Trambauer; Harald Steiner; Evamarie Hey-Hawkins
Journal:  Molecules       Date:  2021-05-11       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.